Under optimal conditions, tissue plasminogen activator (tPA) may be a viable option for treatment of acute ischemic stroke; however, this study showed that protocol is not adhered to in practice and that these protocol deviations are associated with increased mortality and other adverse events. Based on these findings, tPA should not be used in routine clinical practice to treat acute stroke until individual hospitals develop protocols to guarantee the medication's appropriate use.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
acute stroke
8
routine clinical
8
clinical practice
8
detriments tpa
4
tpa acute
4
stroke routine
4
practice optimal
4
optimal conditions
4
conditions tissue
4
tissue plasminogen
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!